收费全文 | 10133篇 |
免费 | 630篇 |
国内免费 | 51篇 |
耳鼻咽喉 | 82篇 |
儿科学 | 175篇 |
妇产科学 | 116篇 |
基础医学 | 1306篇 |
口腔科学 | 576篇 |
临床医学 | 917篇 |
内科学 | 2217篇 |
皮肤病学 | 103篇 |
神经病学 | 1050篇 |
特种医学 | 289篇 |
外国民族医学 | 1篇 |
外科学 | 1958篇 |
综合类 | 40篇 |
一般理论 | 2篇 |
预防医学 | 578篇 |
眼科学 | 197篇 |
药学 | 662篇 |
中国医学 | 51篇 |
肿瘤学 | 494篇 |
2024年 | 12篇 |
2023年 | 118篇 |
2022年 | 237篇 |
2021年 | 414篇 |
2020年 | 228篇 |
2019年 | 349篇 |
2018年 | 437篇 |
2017年 | 282篇 |
2016年 | 296篇 |
2015年 | 362篇 |
2014年 | 496篇 |
2013年 | 592篇 |
2012年 | 903篇 |
2011年 | 887篇 |
2010年 | 490篇 |
2009年 | 451篇 |
2008年 | 652篇 |
2007年 | 670篇 |
2006年 | 578篇 |
2005年 | 543篇 |
2004年 | 430篇 |
2003年 | 356篇 |
2002年 | 299篇 |
2001年 | 67篇 |
2000年 | 44篇 |
1999年 | 60篇 |
1998年 | 47篇 |
1997年 | 37篇 |
1996年 | 32篇 |
1995年 | 13篇 |
1994年 | 15篇 |
1993年 | 11篇 |
1992年 | 27篇 |
1991年 | 35篇 |
1990年 | 27篇 |
1989年 | 21篇 |
1988年 | 43篇 |
1987年 | 24篇 |
1986年 | 32篇 |
1985年 | 13篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1982年 | 13篇 |
1980年 | 7篇 |
1979年 | 16篇 |
1978年 | 8篇 |
1975年 | 10篇 |
1974年 | 18篇 |
1973年 | 13篇 |
1972年 | 8篇 |
OBJECTIVE
To determine the outcome of patients with a urinary cytology test that is unsatisfactory (UUCyt) for evaluation (<50 urothelial cells) to guide the clinical decision‐making process, as currently there are no guidelines to aid in interpreting this result and directing further investigations.PATIENTS AND METHODS
We retrospectively reviewed 142 patients, with 265 instances of UUCyt, in our bladder cancer database and by chart review. The cytology, cystoscopy and pathology results in the subsequent 12 months after a UUCyt result were reviewed, and the incidence of new and recurrent genitourinary tract cancers was calculated.RESULTS
All patients had a previous history of, or developed, urothelial carcinoma during the follow‐up. There were 41 instances (16.3%) in which bladder cancer was evident at the time of the UUCyt and 29% of these tumours were high‐grade. There were another 44 instances (17.5%) in which new or recurrent bladder cancer developed in the subsequent year after a UUCyt test, and many (38.6%) of these tumours were high‐grade.CONCLUSION
The incidence of urothelial carcinoma after a UUCyt was high (33.9%) with a substantial number of high‐grade (34%) tumours, implying that a UUCyt result cannot be interpreted as negative for malignancy. Therefore, in these cases, the urologist must depend on cystoscopy to make a diagnosis. 相似文献Background
The objective of this study was to analyze the factors associated with change in body mass index (BMI) and with percentage of excess weight loss (%EWL) in patients undergoing Roux-en-Y gastric bypass (RYGB). The following factors were analyzed: sex, age, surgical access (laparotomy vs. laparoscopy), preoperative BMI, waist circumference (WC), type 2 diabetes mellitus (T2DM), high blood pressure, and dyslipidemia.Methods
Retrospective cohort study using a convenience sample of 2070 patients of both sexes, aged 18 to 65 years, undergoing RYGB between 2000 and 2013. The outcomes of interest were BMI and %EWL at 0, 6, 12, 18, 24, 30, 36, 42, 48, 54, and 60 months after RYGB.Results
After 36, 48, and 60 months, approximately 50 % of patients had BMI >30 kg/m2. As for %EWL, 60-month results were poor for 17 % of patients (%EWL <50 %), good for 40 % of patients (%EWL 50–75 %), very good for 24 % of patients (%EWL from >75–90 %), and excellent for 19 % of patients (%EWL >90 %). The four most significant predictors of BMI change 60 months after RYGB (in descending order of magnitude) were preoperative BMI, preoperative WC, surgical access, and age; and of %EWL, surgical access, preoperative BMI, preoperative WC, and age.Conclusions
After 60 months of follow-up, the most relevant predictors of weight loss after RYGB were lower preoperative BMI and WC, videolaparoscopy as surgical access, and younger age. Further studies must be carried out to elucidate the impact of these factors on RYGB outcomes.Methods: Two hundred consecutive diabetic patients undergoing on-pump heart surgery were enrolled. A standard insulin protocol based on subcutaneous intermediary insulin was given the morning of the surgery. Intravenous insulin therapy was initiated intraoperatively from blood glucose concentrations of 180 mg/dl or greater and titrated according to a predefined protocol. Poor intraoperative glycemic control was defined as four consecutive blood glucose concentrations greater than 200 mg/dl without any decrease in despite insulin therapy. Postoperative blood glucose concentrations were maintained below 140 mg/dl by using aggressive insulin therapy. The main endpoints were severe cardiovascular, respiratory, infectious, neurologic, and renal in-hospital morbidity.
Results: Insulin therapy was required intraoperatively in 36% of patients, and poor intraoperative glycemic control was observed in 18% of patients. Poor intraoperative glycemic control was significantly more frequent in patients with severe postoperative morbidity (37% vs. 10%; P < 0.001). The adjusted odds ratio for severe postoperative morbidity among patients with a poor intraoperative glycemic control as compared with patients without was 7.2 (95% confidence interval, 2.7-19.0). 相似文献
JAMA. 2008;300(1):60-70.
Context Effective strategies to improve pain management in neonates require a clear understanding of the epidemiology and management of procedural pain. Objective To report epidemiological data on neonatal pain collected from a geographically defined region, based on direct bedside observation of neonates. Design, Setting, and Patients Between September 2005 and January 2006, data on all painful and stressful procedures and corresponding analgesic therapy from the first 14 days of admission were prospectively collected within a 6-week period from 430 neonates admitted to tertiary care centers in the Paris region of France (11.3 millions inhabitants) for the Epidemiology of Procedural Pain in Neonates (EPIPPAIN) study. Main Outcome Measure Number of procedures considered painful or stressful by health personnel and corresponding analgesic therapy. Results The mean (SD) gestational age and intensive care unit stay were 33.0 (4.6) weeks and 8.4 (4.6) calendar days, respectively. Neonates experienced 60 969 first-attempt procedures, with 42 413 (69.6%) painful and 18 556 (30.4%) stressful procedures; 11 546 supplemental attempts were performed during procedures including 10 366 (89.8%) for painful and 1180 (10.2%) for stressful procedures. Each neonate experienced a median of 115 (range, 4-613) procedures during the study period and 16 (range, 0-62) procedures per day of hospitalization. Of these, each neonate experienced a median of 75 (range, 3-364) painful procedures during the study period and 10 (range, 0-51) painful procedures per day of hospitalization. Of the 42 413 painful procedures, 2.1% were performed with pharmacological-only therapy; 18.2% with nonpharmacological-only interventions, 20.8% with pharmacological, nonpharmacological, or both types of therapy; and 79.2% without specific analgesia, and 34.2% were performed while the neonate was receiving concurrent analgesic or anesthetic infusions for other reasons. Prematurity, category of procedure, parental presence, surgery, daytime, and day of procedure after the first day of admission were associated with greater use of specific preprocedural analgesia, whereas mechanical ventilation, noninvasive ventilation and administration of nonspecific concurrent analgesia were associated with lower use of specific preprocedural analgesia. Conclusion During neonatal intensive care in the Paris region, large numbers of painful and stressful procedures were performed, the majority of which were not accompanied by analgesia.